Qingdao Yingpais Health Technology Co., Ltd. (hereinafter referred to as "the Company") and all members of the board of directors guarantee that the information disclosed is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
On March 13, 2026, the Company held the second meeting of the fourth board of directors, where it reviewed and approved the proposal for the share buyback plan. The Company intends to use its own funds and self-raised funds to repurchase part of the issued ordinary shares (A shares) through centralized bidding, which will be used for equity incentives and/or employee stock ownership plans in the future.